Indiana University School of Medicine and Indianapolis-based Indiana University Health are developing a program for genetic testing in heart disease research and clinical care. The program will ...

Cardiovascular diseases (CVD) cause about one in three deaths worldwide. The World Health Organization (WHO) estimates 19.8 million CVD deaths in 2022, roughly 32% of all deaths. Care remains reactive ...

Tailoring medicines to an individual’s genetic profile is now possible. One critical aspect is genetic testing that reduces side effects, particularly for patients on psychiatric and cardiovascular ...

Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention and early detection more precise, has ...

Among cardiologists, it’s known that transthyretin cardiac amyloidosis, a type of heart disease, is caused by the misfolding of a protein called transthyretin, which builds up in the walls of the ...